[Urothelial tumors and the extracellular matrix].
The network of both intra- and intercellular, either physical (bioconductive connectional system) and/or chemical signals, plays a significant role in the maintenance of tissue architecture and integrity of epithelial cell layers. The basement membrane is not only a static barrier but a dynamic regulator of the urothelium. Any change in the basement membrane can lead, by the extracellular matrix-cytoskeleton-nuclear matrix interaction, to altered gene regulation of the urothelial cells. Abnormal production and deposition or proteolytic degradation of the extracellular matrix components correlate with tumour stage and progression. In some experimental models, tissue inhibitors of metalloproteinases or anti-proteinase antibodies can abrogate the proteolytic activity of those matrix metalloproteinase enzymes (collagenase IV, cathepsin, stromelysin, etc.) which promote tumour invasion. Finally, the current researches investigating the use of biologic protein (e.g., TIMP-1 e-2; agents that affect angiogenesis and spread of neoplasias) are aimed at offer new therapeutic opportunities in oncology.
Alberti
C
C
Cattedra e Scuola di Specializzazione di Urologia, Università degli Studi di Parma.
Frattini
A
A
Ferretti
S
S
D001485:Basement Membrane / Q000473:pathology; D055592:Biophysical Phenomena; D001703:Biophysics; D005109:Extracellular Matrix / Q000378:metabolism*; D016326:Extracellular Matrix Proteins / Q000502:physiology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008954:Models, Biological; D009361:Neoplasm Invasiveness; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D015398:Signal Transduction; D014571:Urologic Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000628:therapy
D016326:Extracellular Matrix Proteins; D007155:Immunologic Factors